Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 3/20 | 0.46 |
| ▸ | FKBP1A | P62942 | 5/20 | 0.46 |
| ▸ | ACE | P12821 | 3/20 | 0.45 |
| ▸ | FAP | Q12884 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29483482 | 0.86 | PREP (0.47) | PREPFKBP1AACEFAPTSHR | |
| SCHEMBL30051887 | 0.79 | DPP4 (0.46) | PREPACEFAPDPP8 | |
| SCHEMBL30187740 | 0.77 | FKBP1A (0.54) | PREPFKBP1AACEKMT2ADPP8 | |
| SCHEMBL15371266 | 0.76 | DPP8 (0.57) | FKBP1AACEFAPDPP8 | |
| SCHEMBL8110892 | 0.76 | DPP8 (0.57) | FKBP1AACEFAPDPP8 | |
| SCHEMBL10402287 | 0.76 | DPP8 (0.57) | FKBP1AACEFAPDPP8 | |
| SCHEMBL8365050 | 0.76 | DPP8 (0.57) | FKBP1AACEFAPDPP8 | |
| Hydrochloric Acid SCHEMBL9034318 | 0.75 | DPP8 (0.56) | FKBP1AACEFAPDPP8 | |
| Hydrochloric Acid SCHEMBL9034326 | 0.75 | DPP8 (0.56) | FKBP1AACEFAPDPP8 | |
| Hydrochloric Acid SCHEMBL27869985 | 0.75 | DPP8 (0.56) | FKBP1AACEFAPDPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604313-A | IL-2 pre-cytokine antibody fusion proteins | 普罗维瓦疗法香港有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119591725-A | IL-2 compositions and methods of use thereof | 普罗维瓦疗法香港有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-112512559-B | Compositions and methods for treating NRP 2-related diseases | ATYR 医药公司 | 2025-02-28 | — | — | CN | disclosed |